We are live on ! Find out more
BC

BIT Capital Portfolio holdings

AUM $2.07B
1-Year Est. Return 157.17%
This Fund
S&P 500
This Quarter Est. Return
+16.08%
1 Year Est. Return
+157.17%
3 Year Est. Return
+781.63%
5 Year Est. Return
+899.06%
10 Year Est. Return
–
AUM
$1.28B
AUM Growth
-$71.7M
Cap. Flow
-$170M
Cap. Flow %
-13.32%
Top 10 Hldgs %
58.87%
Holding
132
New
24
Increased
25
Reduced
34
Closed
30

Top Buys

Rank Stock Value
1
DUOL icon
Duolingo
DUOL
+$93.5M
2
TSM icon
TSMC
TSM
+$26.9M
3
MU icon
Micron Technology
MU
+$20.9M
4
HIMS icon
Hims & Hers Health
HIMS
+$17.5M
5
MSFT icon
Microsoft
MSFT
+$15.1M

Top Sells

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$48.7M
2
META icon
Meta Platforms (Facebook)
META
+$40.2M
3
IREN icon
Iris Energy
IREN
+$32.1M
4
AFRM icon
Affirm
AFRM
+$28.9M
5
TSLA icon
Tesla
TSLA
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 34.54%
2 Financials 22.86%
3 Healthcare 14.97%
4 Consumer Discretionary 8.48%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DQ
51
Daqo New Energy
DQ
$821M
$2.34M 0.18%
160,597
– –
AMD icon
52
CALL
Advanced Micro Devices
AMD
$808B
$2.29M 0.18%
14,100
– –
ARVN icon
53
Arvinas
ARVN
$517M
$2.16M 0.17%
80,972
-61,734
-43% -$1.97M
ARGX icon
54
argenx
ARGX
$53.8B
$2.02M 0.16%
4,694
– –
DNLI icon
55
Denali Therapeutics
DNLI
$3.7B
$2M 0.16%
86,177
+4,177
+5% +$80.2K
SLN
56
Silence Therapeutics
SLN
$496M
$1.92M 0.15%
101,235
+12,235
+14% +$260K
VRDN icon
57
Viridian Therapeutics
VRDN
$1.99B
$1.89M 0.15%
145,556
– –
INCY icon
58
Incyte
INCY
$23.4B
$1.79M 0.14%
29,551
+7,097
+32% +$402K
AFRM icon
59
Affirm
AFRM
$25.5B
$1.76M 0.14%
58,189
-899,847
-94% -$28.9M
SNDX icon
60
Syndax Pharmaceuticals
SNDX
$2.02B
$1.64M 0.13%
79,786
+12,822
+19% +$268K
NUVB icon
61
Nuvation Bio
NUVB
$2.02B
$1.62M 0.13%
+555,069
New +$1.69M
DAWN
62
DELISTED
Day One Biopharmaceuticals
DAWN
$1.46M 0.11%
106,182
– –
CHRS icon
63
Coherus Oncology
CHRS
$216M
$1.45M 0.11%
838,947
-20,814
-2% -$41.9K
RARE icon
64
Ultragenyx Pharmaceutical
RARE
$2.88B
$1.33M 0.1%
32,255
-8,745
-21% -$373K
JANX icon
65
Janux Therapeutics
JANX
$992M
$1.31M 0.1%
31,223
-100
-0.3% -$4.7K
MSTR icon
66
Strategy Inc
MSTR
$34.4B
$1.3M 0.1%
+9,470
New +$1.36M
BAP icon
67
Credicorp
BAP
$31B
$1.28M 0.1%
7,964
+3,099
+64% +$513K
GRAB icon
68
Grab
GRAB
$14.6B
$1.2M 0.09%
336,978
+143,577
+74% +$504K
VKTX icon
69
CALL
Viking Therapeutics
VKTX
$4.31B
$1.19M 0.09%
+22,500
New +$1.47M
BDTX icon
70
Black Diamond Therapeutics
BDTX
$103M
$1.18M 0.09%
253,394
-21,913
-8% -$118K
NOW icon
71
ServiceNow
NOW
$106B
$1.18M 0.09%
7,475
-65,020
-90% -$9.54M
UPST icon
72
Upstart Holdings
UPST
$2.82B
$1.14M 0.09%
+48,483
New +$1.17M
LYV icon
73
Live Nation Entertainment
LYV
$41.9B
$1.12M 0.09%
+11,925
New +$1.13M
IMCR icon
74
Immunocore
IMCR
$1.78B
$1.11M 0.09%
32,749
+18,845
+136% +$961K
CME icon
75
CME Group
CME
$88.5B
$1.08M 0.08%
+5,474
New +$1.13M
1 2
3
4 5

Similar funds

HHGA
Halbert Hargrove Global Advisors Long Beach, California $2.07B AUM 19% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.07B AUM 4.33% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
3AM
3EDGE Asset Management Naples, Florida $2.07B AUM 16.66% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

BIT Capital's Q2 2024 Portfolio in Review

As of Q2 2024, BIT Capital held 132 positions worth $1.28B, down 5.3% from $1.35B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

BIT Capital withdrew a net $170M in Q2 2024, closing 30 positions and reducing 34 holdings. Its most notable exit was Tesla, an estimated $27.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, BIT Capital opened a new position in Duolingo worth $95.3M.

  • BIT Capital's largest Q2 2024 buy was Duolingo: 456,511 shares worth $95.3M.
  • BIT Capital added most to TSMC in Q2 2024, an estimated $26.9M increase.
  • BIT Capital's biggest Q2 2024 reduction was Coinbase, cutting an estimated $48.7M.
  • BIT Capital fully exited Tesla in Q2 2024, selling an estimated $27.7M.
  • BIT Capital's ten largest holdings make up 59% of its $1.28B portfolio in Q2 2024.
  • BIT Capital opened 24 new positions and closed 30 in Q2 2024.
  • BIT Capital's portfolio value fell 5.3% quarter-over-quarter to $1.28B.

Based on BIT Capital's 13F filing for Q2 2024, filed 12 Feb 2025.